Biochemical markers of acromegaly: GH vs. IGF-I

Growth Hormone and IGF Research

Volumn 14, Issue SUPPL. A, 2004, Pages

  Barkan, Ariel L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acromegaly; Biochemical markers; Diagnosis; Growth hormone; Insulin like growth factor

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; GROWTH HORMONE; PROTIRELIN; SOMATOMEDIN C;

ACCURACY; ACROMEGALY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; EARLY DIAGNOSIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; METABOLIC PARAMETERS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 2542525315     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.03.022     Document Type: Review

References (15)

1. A. Giustina, A. Barkan, F.F. Casanueva, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement, J. Clin. Endocrinol. Metab. 85 (2000) 526-529.
2. E. Dimaraki, C.A. Jaffe, R. DeMott-Friberg, W.F. Chandler, A.L. Barkan, Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up, J. Clin. Endocrinol. Metab. 87 (2002) 3537-3542.
3. S.R. Peacey, A.A. Toogood, J.D. Veldhuis, M.O. Thorner, S.M. Shalet, The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy, J. Clin. Endocrinol. Metab. 86 (2001) 259-266.
4. K. Kim, K. Arai, N. Sanno, A. Teramoto, T. Shibasaki, The expression of thyrotrophin-releasing hormone 1 messenger ribonucleic acid in human pituitary adenomas, Clin. Endocrinol. 54 (2001) 309-316.
5. N.R. Biermasz, J.W. Smith, H. van Dulken, F. Roelfsema, Postoperative persistent thyrotropin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly, Clin. Endocrinol. 56 (2002) 313-319.
6. K. Mukada, The natural course of growth hormone-secreting pituitary adenomas after surgery alone-clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone, Neurol. Med. Chir. 30 (1990) 251-257.
7. P.M. Stewart, S. Smith, J. Seth, S.E. Stewart, D. Cole, C.R. Edwards, Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay, Ann. Clin. Biochem. 26 (1989) 205-206.
8. P.U. Freda, R.E. Landman, R.E. Sundeen, K.D. Post, Gender and age in the biochemical assessment of cure of acromegaly, Pituitary 4 (2001) 163-171.
9. A.C. Costa, A. Rossi, C.E. Martinelli Jr., H.R. Machado, A.C. Morelra, Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?, J. Clin. Endocrinol. Metab. 87 (2002) 3142-3147.
10. A.A. Butler, S. Yakar, D. LeRoith, Insulin-like growth factor-I: compartmentalization within the somatotropic axis, News Physiol. Sci. 17 (2002) 82-85.
11. J. Isgaard, L. Carlsson, O.G. Isaksson, J.O. Jansson, Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion, Endocrinology 123 (1988) 2605-2610.
12. C.A. Jaffe, D.K. Turgeon, K. Lown, R. DeMott-Friberg, P.B. Watkins, Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans, Am. J. Physiol. Endocrinol. Metab. 283 (2002) 1008-1015.
13. A.L. Barkan, I.Z. Beitins, R.P. Kelch, Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion, J. Clin. Endocrinol. Metab. 67 (1988) 69-73.
14. D.R. Clemmons, J.J. VanWyk, E.C. Ridgway, B. Kliman, R.N. Kjellberg, L.E. Underwood, Evaluation of acromegaly by radioimmunoassay of somatomedin-C, New Engl. J. Med. 301 (1979) 1138-1142.
15. P.U. Freda, A.T. Nuruzzaman, K.D. Post, Significance of "abnormal" GH suppression after OGTT with normal IGF-I levels in postoperative patients with acromegaly, 84th Annual Meeting of the Endocrine Society, San Francisco, CA, 2002, 19-22 June.